BiotechTube
Home/TG Therapeutics/David T. Y. Liu
DT

David T. Y. Liu

Head of Business Development and Strategy

TG Therapeutics

Therapeutic Areas

Multiple SclerosisHematologic MalignanciesAutoimmune Diseases

TG Therapeutics Pipeline

DrugIndicationPhase
BRIUMVI (ublituximab)Relapsing Forms of Multiple SclerosisApproved
UblituximabNewly Diagnosed Multiple SclerosisPhase 3
TG-1701B-Cell MalignanciesPhase 1
TG-1801B-Cell MalignanciesPhase 1

Leadership Team at TG Therapeutics

MS
Michael S. Weiss
Executive Chairman and Chief Executive Officer
SA
Sean A. Power
Chief Financial Officer
SL
Sagar Lonial
Chief Medical Officer
JM
Jenna M. Goldberg
General Counsel and Corporate Secretary
View full TG Therapeutics profile